Clinical trial
A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring…
NCT00216190 · Hospira, now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00216190 |
|---|---|
| Title | A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation |
| Official title | A Phase 4, Randomized, Double-Blind, Multi-Center, Comparator Study Evaluating the Safety and Efficacy of Dexmedetomidine Compared to IV Midazolam in ICU Subjects Requiring Greater Than Twenty-Four Hours of Continuous Sedation |
| Lead sponsor | Hospira, now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Mechanically Ventilated and Intubated Subjects |
| Intervention type | Drug |
| Interventions | Dexmedetomidine HCL Injection, Midazolam Injection |
| Enrollment | 420 |
| Start date | Mar 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 23, 2015 |
| Countries | Argentina, Australia, Brazil, New Zealand, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: